Association between coexisting hypertension, dyslipidaemia and elevated C reactive protein with cardiovascular disease and mortality: a cross-sectional and longitudinal analysis in a representative cohort of older US adults
Objective Hypertension and dyslipidaemia are established risk factors for cardiovascular disease (CVD) but they are often insufficient on their own to predict CVD. Inflammation also contributes to CVD, but research on the co-occurrence of inflammation, hypertension and dyslipidaemia and CVD risk is...
Saved in:
| Main Authors: | Thomas Leonidas Karadimas, Helen C S Meier |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-10-01
|
| Series: | BMJ Public Health |
| Online Access: | https://bmjpublichealth.bmj.com/content/2/2/e000455.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated high-sensitivity C-reactive protein and dyslipidaemia in type 2 diabetes mellitus: implications for cardiovascular risk prediction in Nigerian patients
by: Jamila Aminu Mohammed, et al.
Published: (2025-04-01) -
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
by: Alberto J Lorenzatti, et al.
Published: (2020-02-01) -
Secondary dyslipidaemia
by: D.J. Blom
Published: (2011-07-01) -
THE HIGH ELEVATION OF C-REACTIVE PROTEIN LEVELS AT ADMISSION REPRESENTS AN EARLY MORTALITY PREDICTOR IN PATIENTS WITH COMPLICATED INTRA-ABDOMINAL INFECTIONS
by: E. Dimitrov, et al.
Published: (2020-12-01) -
Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
by: M R Essop, et al.
Published: (2023-11-01)